Literature DB >> 17938278

Osteopontin expression in normal skin and non-melanoma skin tumors.

Pi-Ling Chang1, Louie Harkins, Yu-Hua Hsieh, Patricia Hicks, Kraisorn Sappayatosok, Somchai Yodsanga, Somporn Swasdison, Ann F Chambers, Craig A Elmets, Kang-Jey Ho.   

Abstract

Osteopontin (OPN) is an adhesive, matricellular glycoprotein, whose expression is elevated in many types of cancer and has been shown to facilitate tumorigenesis in vivo. To understand the role of OPN in human skin cancer, this study is designed to determine whether OPN is expressed in premalignant [solar/actinic keratosis (AK)] and in malignant skin lesions such as squamous cell carcinomas (SCC) and basal cell carcinomas (BCC), as well as in normal skin exposed or not exposed to sunlight. Immunohistochemical analyses showed that OPN is expressed in SCC (20/20 cases) and in AK (16/16 cases), which are precursors to SCC, but is absent or minimally expressed in solid BCC (17 cases). However, positive staining for OPN was observed in those BCC that manifest differentiation toward epidermal appendages such as keratotic BCC. In sunlight-exposed normal skin, OPN is minimally expressed in the basal cell layer, but in contrast to those not exposed to sunlight, OPN is more prominent in the spinous cell layer with increasing intensity toward the granular cell layer. Additionally, OPN is expressed in the hair follicles, sebaceous glands, and sweat glands of normal skin. In conclusion, these data suggest that OPN is associated with keratinocyte differentiation and that it is expressed in AK and SCC, which have metastatic potential, but minimally expressed in solid BCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17938278      PMCID: PMC2323122          DOI: 10.1369/jhc.7A7325.2007

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  75 in total

1.  Stimulation of osteopontin mRNA expression in HL-60 cells is independent of differentiation.

Authors:  K B Atkins; R U Simpson; M J Somerman
Journal:  Arch Biochem Biophys       Date:  1997-07-15       Impact factor: 4.013

Review 2.  The role of integrins in tumorigenesis and metastasis.

Authors:  R J Sanders; F Mainiero; F G Giancotti
Journal:  Cancer Invest       Date:  1998       Impact factor: 2.176

3.  The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas.

Authors:  M R Gailani; M Ståhle-Bäckdahl; D J Leffell; M Glynn; P G Zaphiropoulos; C Pressman; A B Undén; M Dean; D E Brash; A E Bale; R Toftgård
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

4.  Osteopontin expression in lung cancer.

Authors:  A F Chambers; S M Wilson; N Kerkvliet; F P O'Malley; J F Harris; A G Casson
Journal:  Lung Cancer       Date:  1996-11       Impact factor: 5.705

Review 5.  Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion.

Authors:  D E Brash; A Ziegler; A S Jonason; J A Simon; S Kunala; D J Leffell
Journal:  J Investig Dermatol Symp Proc       Date:  1996-04

6.  Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

Authors:  A Bellahcène; V Castronovo
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

7.  Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas.

Authors:  J M Spencer; S M Kahn; W Jiang; V A DeLeo; I B Weinstein
Journal:  Arch Dermatol       Date:  1995-07

8.  Enhanced expression of alpha v integrin subunit and osteopontin during differentiation of HL-60 cells along the monocytic pathway.

Authors:  M J Somerman; J E Berry; Z Khalkhali-Ellis; P Osdoby; R U Simpson
Journal:  Exp Cell Res       Date:  1995-02       Impact factor: 3.905

9.  Osteopontin is a constitutive component of normal elastic fibers in human skin and aorta.

Authors:  M Baccarani-Contri; F Taparelli; I Pasquali-Ronchetti
Journal:  Matrix Biol       Date:  1995-07       Impact factor: 11.583

10.  Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro.

Authors:  S R Rittling; H N Matsumoto; M D McKee; A Nanci; X R An; K E Novick; A J Kowalski; M Noda; D T Denhardt
Journal:  J Bone Miner Res       Date:  1998-07       Impact factor: 6.741

View more
  14 in total

1.  Pre- and post-translational regulation of osteopontin in cancer.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Commun Signal       Date:  2011-04-26       Impact factor: 5.782

Review 2.  Role of osteopontin in the pathophysiology of cancer.

Authors:  Lalita A Shevde; Rajeev S Samant
Journal:  Matrix Biol       Date:  2014-03-19       Impact factor: 11.583

3.  Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.

Authors:  Smruthy Sivakumar; F Anthony San Lucas; Tina L McDowell; Wenhua Lang; Li Xu; Junya Fujimoto; Jianjun Zhang; P Andrew Futreal; Junya Fukuoka; Yasushi Yatabe; Steven M Dubinett; Avrum E Spira; Jerry Fowler; Ernest T Hawk; Ignacio I Wistuba; Paul Scheet; Humam Kadara
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

4.  Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway.

Authors:  Xianmin Luo; Megan K Ruhland; Ermira Pazolli; Anne C Lind; Sheila A Stewart
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

5.  Host-derived osteopontin maintains an acute inflammatory response to suppress early progression of extrinsic cancer cells.

Authors:  Yu-Hua Hsieh; M Margaret Juliana; Kang-Jey Ho; Hui-Chien Kuo; Henri van der Heyde; Craig Elmets; Pi-Ling Chang
Journal:  Int J Cancer       Date:  2011-10-20       Impact factor: 7.396

6.  The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems.

Authors:  Yasuto Kunii; Shin-ichi Niwa; Yoshiaki Hagiwara; Masahiro Maeda; Tsutomu Seitoh; Toshimitsu Suzuki
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

7.  Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.

Authors:  Pi-Ling Chang; Yu-Hua Hsieh; Chao-Cheng Wang; M Margaret Juliana; Yuko Tsuruta; Laura Timares; Craig Elmets; Kang-Jey Ho
Journal:  J Dermatol Sci       Date:  2014-05-21       Impact factor: 4.563

8.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

9.  CD10 and osteopontin expression in dentigerous cyst and ameloblastoma.

Authors:  Shaimaa M Masloub; Adel M Abdel-Azim; Ehab S Abd Elhamid
Journal:  Diagn Pathol       Date:  2011-05-24       Impact factor: 2.644

10.  Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.

Authors:  Jessica S Kim; Muhammad M Bashir; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2012-03-29       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.